*
*Osteoporosis|64859006
*
*
("porous bones",|272673000|128530007
from Greek|1451003
: ??????/_ostoun_ meaning "bone"|272673000|3138006|90780006|128530007
and ?????/_poros_ meaning "pore"
)
is
a disease|64572001
of bones|272673000|128530007
that
leads|88488004|236874000
to an increased risk|35105006|30207005|260366006|30207005
of fracture.|125605004

In osteoporosis,|64859006
the bone mineral density (BMD)|272673000|87918000|125146005|3138006|87918000|125146005|90780006|87918000|125146005|128530007|87918000|125146005
is
reduced,|260400001
bone microarchitecture deteriorates,|272673000|3138006|90780006|128530007
and
the amount|107651007
and
variety
of proteins|88878007
in bone|272673000|3138006|90780006|128530007
are
altered.

Osteoporosis|64859006
is
defined
by the World Health Organization (WHO)|263775005|21139007
as a bone mineral density|272673000|87918000|125146005|3138006|87918000|125146005|90780006|87918000|125146005|128530007|87918000|125146005
of 2.5 standard deviations|264655001|386136009
or
more
below the mean peak bone mass|255586005|255587001|272673000|300848003|255586005|255587001|272673000|118538004|255586005|255587001|3138006|300848003|255586005|255587001|3138006|118538004|255586005|255587001|90780006|300848003|255586005|255587001|90780006|118538004|255586005|255587001|128530007|300848003|255586005|255587001|128530007|118538004
(average
of young, healthy adults|84422007|102512003
)
as
measured|258104002
by dual-energy X-ray absorptiometry|248272003|248272003|52250000|248272003|168537006|248272003|363680008
;
the term "established osteoporosis"|263748003|64859006|385645004|64859006
includes|55919000
the presence|386397008
of a fragility fracture.|59955000|125605004

The disease|64572001
may
be
classified|73504009
as primary type 1,|63161005|258191002|261424001|258191002
primary type 2,|63161005|258195006|261424001|258195006
or
secondary.|2603003|81170007

The form|246176004
of osteoporosis|64859006
most common|4757001|72906007
in women|224526002
after menopause|161712005
is
referred to|439980006
as
primary type 1|63161005|258191002|261424001|258191002
or
postmenopausal osteoporosis.|102447009

Primary type 2 osteoporosis|276661002|258195006
or
senile osteoporosis|18040001
occurs|272120004
after age 75|424144002
and
is
seen
in
both
females|248152002
and
males|248153007
at a ratio|118586006
of 2|260306008
:
1.

Finally,
secondary osteoporosis|2603003|64859006|81170007|64859006
may
arise|68727004
at any age|424144002
and
affect|4065008
men|339947000
and
women equally.|224526002

This form|246176004
results|394617004
from chronic predisposing medical problems|90734009|74188005|55607006
or
disease,|64572001
or
prolonged use|255224006|277889008|255224006|419385000
of medications|410942007
such as glucocorticoids,|419933005
when
the disease|64572001
is
called steroid-|116566001
or
glucocorticoid-induced osteoporosis.|419933005|16404004|64859006

Osteoporosis risks|64859006|30207005
can
be
reduced|260400001
with lifestyle changes|60134006|243326001|60134006|263703002
and
sometimes medication|410942007
;
in people|125676002
with osteoporosis,|64859006
treatment|276239002|416118004
may
involve|248448006
both.

Lifestyle change|60134006|243326001|60134006|263703002
includes|55919000
diet|41829006
and
exercise,|61686008
and
preventing falls.|1912002|116699007|1912002

Medication|410942007
includes|55919000
calcium,|5540006
vitamin D,|71516007|30178006
bisphosphonates|372907000
and
several others.|261028005

Fall-prevention advice|386296001|420227002
includes|55919000
exercise|61686008
to tone deambulatory muscles,|6918002
proprioception-improvement exercises|61686008|229065009
;
equilibrium therapies|249982003|276239002
may
be
included.|55919000

Exercise|61686008
with its anabolic effect,|111151007|253861007
may
at the same time stop|262126009|410669006|422117008
or
reverse osteoporosis.|64859006

Osteoporosis|64859006
is
a component|246093002
of the frailty syndrome.|248279007

Osteoporosis|64859006
itself
has
no symptoms
;
its main consequence|63161005|103332005
is
the increased risk|35105006|30207005|260366006|30207005
of bone fractures.|125605004

Osteoporotic fractures|46675001
occur|272120004
in situations
where healthy people|263775005|125676002
would
not normally
break
a bone|272673000|3138006|90780006|128530007
;
they
are
therefore
regarded
as fragility fractures.|59955000|125605004

Typical fragility fractures|59955000|125605004
occur|272120004
in the vertebral column,|421060004|44300000
rib,|113197003|302523002
hip|29836001|85710004
and
wrist.|8205005|361289009|74670003

Fractures|125605004
are
the most dangerous aspect|4757001
of osteoporosis.|64859006

Debilitating
acute|272118002
and
chronic pain|82423001
in the elderly|105436006
is
often|70232002
attributed|246061005
to fractures|125605004
from osteoporosis|64859006
and
can
lead|88488004
to further disability|46053002|21134002
and
early mortality.|264499004|409651001

These fractures|125605004
may
also
be
asymptomatic.|84387000

The symptoms
of a vertebral collapse|84138006
("compression fracture"|443395009
)
are
sudden back pain,|255363002|22913005
often|70232002
with radiculopathic pain|22253000
(shooting pain|49575005
due to nerve root compression|84116009|85077000|84116009|2338009|40958000|71173004|40958000|263720003
)
and
rarely|103356009
with spinal cord compression|71286001
or
cauda equina syndrome.|192970008

Multiple vertebral fractures|134291007|420345000
lead|88488004
to a stooped posture,|363855006
loss
of height,
and
chronic pain|82423001
with resultant reduction|58294000|260400001|289928003
in mobility.[4]|363803005|246197003

Fractures|125605004
of the long bones acutely|113193004
impair|260379002|40226000
mobility|363803005|246197003
and
may
require
surgery.|83578000

Hip fracture,
in particular, usually
requires
prompt surgery,|83578000
as
serious risks|42745003|30207005
are
associated|47429007
with it,
such as deep vein thrombosis|128053003|404223003
and
pulmonary embolism,|59282003
and
increased mortality.|35105006|409651001|260366006|409651001

Fracture risk calculators|125605004|30207005
assess
the risk|30207005
of fracture|125605004
based|418836005
upon several criteria,|261028005
including|55919000
BMD,
age,|424144002
smoking|365981007
,
alcohol usage,|419442005|277889008|53041004|277889008|430837008|277889008
weight,|27113001|272102008|39857003
and
gender.|263495000

Recognised calculators
include|55919000
FRAX[5]
and
Dubbo.

The increased risk|35105006|30207005|260366006|30207005
of falling|1912002
associated|47429007
with aging|248280005
leads|88488004|236874000
to fractures|125605004
of the wrist,|8205005|361289009|74670003
spine,|421060004|44300000|243930007
and
hip.|29836001|85710004

The risk|30207005
of falling,|1912002
in turn,|282987006
is
increased|35105006|260366006
by impaired eyesight|260379002|40226000
due to any cause|134198009
(e.g.|258795003

glaucoma,|23986001
macular degeneration,|422338006|267718000
balance disorder,|298313002
movement disorders|60342002
(e.g.|258795003

Parkinson's disease,|49049000
dementia,|12348006|52448006
and
sarcopenia
(age-related loss|424144002|272151006|424144002|262094002
of skeletal muscle.|127954009|244716004

Collapse|27942005|16277007|271787007
(transient loss|14803004
of postural tone|35799003|223628004|35799003|258691001
with
or
without loss
of consciousness|106167005
)
leads|88488004|236874000
to a significant risk|386134007|30207005
of falls|1912002
;
causes|134198009
of syncope|271594007
are
manifold,
but
may
include|55919000
cardiac arrhythmias
(irregular heart beat|361138002
)
,
vasovagal syncope,|398665005
orthostatic hypotension|28651003
(abnormal drop|263654008|404218003
in blood pressure|75367002|392570002|386536003
on standing|10904000
up
)
,
and
seizures.|91175000

Removal|118292001|128303001
of obstacles
and
loose carpets|78799005
in the living environment|276339004
may
substantially
reduce|260400001
falls.|1912002

Those with previous falls,|20401003|9130008|1912002|421463005|9130008|1912002
as well as
those
with gait|271705001
or
balance disorders,|298313002
are
most at risk.[6]|410519009

Risk factors|80943009
for osteoporotic fracture|46675001
can
be
split
between nonmodifiable
and
(potentially
)
modifiable.

In addition,|260364009
osteoporosis|64859006
is
a recognized complication|116223007|263718001
in specific diseases|69658003|64572001
and
disorders.|64572001

Medication use|410942007|277889008|410942007|419385000
is
theoretically modifiable,
although
in many cases,|398241000|413769002
the use|277889008|419385000
of medication|410942007
that
increases|260366006
osteoporosis risk|64859006|30207005
is
unavoidable.

Caffeine|255641001
is
not
a risk factor|80943009
for osteoporosis.[7]|64859006

The most important risk factors|4757001|80943009
for osteoporosis|64859006
are
advanced|86005002
age|424144002
(
in
both
men|339947000
and
women|224526002
)
and
female sex|248152002
;
estrogen deficiency|61946003|260372006|61946003|248325000
following|255260001
menopause|161712005
or
oophorectomy|83152002
is
correlated
with a rapid reduction|255358001|58294000|255358001|260400001|255358001|289928003
in bone mineral density,|272673000|87918000|125146005|3138006|87918000|125146005|90780006|87918000|125146005|128530007|87918000|125146005
while
in men,|339947000
a decrease|260400001|260370003
in testosterone levels|104957004
has
a comparable
(
but
less
pronounced
)
effect.|253861007

While
osteoporosis|64859006
occurs|272120004
in people|125676002
from all ethnic groups,|397731000
European|414152003
or
Asian ancestry predisposes|414978006
for osteoporosis.|64859006

Those with a family history|20401003|57177007|421463005|57177007
of fracture|125605004
or
osteoporosis|64859006
are
at an increased risk|35105006|30207005|260366006|30207005
;
the heritability|255404009
of the fracture,|125605004
as well as
low bone mineral density,|62482003|272673000|87918000|125146005|62482003|3138006|87918000|125146005|62482003|90780006|87918000|125146005|62482003|128530007|87918000|125146005|371880002|272673000|87918000|125146005|371880002|3138006|87918000|125146005|371880002|90780006|87918000|125146005|371880002|128530007|87918000|125146005
are
relatively high,|75540009|371879000
ranging
from 25
to 80%.

At least 30 genes|276139006|67271001|263796003|67271001
are
associated|47429007
with the development|278923009
of osteoporosis.|64859006

Those
who
have
already
had
a fracture|125605004
are
at least twice|276139006|421832002|263796003|421832002
as
likely to|2931005
have
another fracture|125605004
compared
to someone
of the same age|262126009|424144002
and
sex.|258139002|365952006|263495000|70256003|57312000

A small stature
is
also
a nonmodifiable risk factor|80943009
associated|47429007
with the development|278923009
of osteoporosis.[1]|64859006

Many diseases|260396001|64572001
and
disorders|64572001
have
been
associated|47429007
with osteoporosis.|64859006

For some,
the underlying mechanism|257544000
influencing
the bone metabolism|272673000|47722004|3138006|47722004|90780006|47722004|128530007|47722004
is
straightforward,|385666007
whereas
for others|74964007
the causes|134198009
are
multiple|260396001
or
unknown.|261665006

Certain medications|17162000|410942007
have
been
associated|47429007
with an increase|260366006
in osteoporosis risk|64859006|30207005
;
only steroids|50607009|116566001|420295001|116566001
and
anticonvulsants|255632006
are
classically
associated|47429007
,
but
evidence|18669006
is
emerging
with regard
to other drugs.|74964007|410942007

The underlying mechanism|257544000
in all cases|398241000|413769002
of osteoporosis|64859006
is
an imbalance
between bone resorption|22200009
and
bone formation.|83323007

In normal bone,|17621005|272673000|17621005|3138006|17621005|90780006|17621005|128530007|258744000|272673000|258744000|3138006|258744000|90780006|258744000|128530007
matrix remodeling
of bone|272673000|3138006|90780006|128530007
is
constant
;
up to 10%
of all bone mass|272673000|300848003|272673000|118538004|3138006|300848003|3138006|118538004|90780006|300848003|90780006|118538004|128530007|300848003|128530007|118538004
may
be
undergoing remodeling
at any point in time.|272105005

The process|415178003
takes|419652001
place|257557008|421066005
in bone multicellular units (BMUs)|272673000|258666001|3138006|258666001|90780006|258666001|128530007|258666001
as
first
described
by Frost
in 1963.

Bone|272673000|3138006|90780006|128530007
is
resorbed
by osteoclast cells|27770000|4421005
(
which
derive
from the bone marrow,|279729006
after
which new bone|7147002|272673000|7147002|3138006|7147002|90780006|7147002|128530007
is
deposited|46595003
by osteoblast cells.[9]|48156001|4421005

The three main mechanisms|421291004|63161005|257544000
by which osteoporosis|64859006
develops
are
an inadequate peak bone mass|71978007|255587001|272673000|300848003|71978007|255587001|272673000|118538004|71978007|255587001|3138006|300848003|71978007|255587001|3138006|118538004|71978007|255587001|90780006|300848003|71978007|255587001|90780006|118538004|71978007|255587001|128530007|300848003|71978007|255587001|128530007|118538004
(
the skeleton|113192009|361378004
develops
insufficient mass|71978007|300848003|71978007|118538004|423437008|300848003|423437008|118538004
and
strength|260404005
during growth
)
,
excessive bone resorption,|260378005|22200009
and
inadequate formation|71978007|11798007|71978007|255277001
of new bone|7147002|272673000|7147002|3138006|7147002|90780006|7147002|128530007
during remodeling.

An interplay
of these three mechanisms|421291004|257544000
underlies|255546002
the development|278923009
of fragile bone tissue.|59955000|3138006

Hormonal factors strongly|278994005
determine
the rate
of bone resorption|22200009
;
lack|41277001
of estrogen|61946003
(e.g.|258795003

as a result|394617004
of menopause|161712005
)
increases|260366006
bone resorption,|22200009
as well as
decreasing|260371004
the deposition|46595003
of new bone|7147002|272673000|7147002|3138006|7147002|90780006|7147002|128530007
that normally
takes|419652001
place|257557008|421066005
in weight-bearing bones.|249981005|272673000|249981005|128530007

The amount|107651007
of estrogen|61946003
needed|410525008|103325001
to
suppress|245780008
this process|415178003
is
lower|261122009
than
that normally
needed|410525008|103325001
to
stimulate
the uterus|35039007|181452004
and
breast gland.

The ?-form|246176004
of the estrogen receptor|23307004
appears
to
be
the most important|4757001
in
regulating
bone turnover.|272673000|261032004|3138006|261032004|90780006|261032004|128530007|261032004

In addition|260364009
to estrogen,|61946003
calcium metabolism|5540006|47722004
plays|300776002
a significant role|386134007
in bone turnover,|272673000|261032004|3138006|261032004|90780006|261032004|128530007|261032004
and
deficiency|260372006|248325000
of calcium|5540006
and
vitamin D|71516007|30178006
leads|88488004|236874000
to impaired bone deposition|260379002|272673000|46595003|260379002|3138006|46595003|260379002|90780006|46595003|260379002|128530007|46595003|40226000|272673000|46595003|40226000|3138006|46595003|40226000|90780006|46595003|40226000|128530007|46595003
;
in addition,|260364009
the parathyroid glands|111002
react
to low calcium levels|62482003|71878006|371880002|71878006
by secreting parathyroid hormone|4076007|428295002
(parathormone,|4076007
PTH
)
,
which
increases|260366006
bone resorption to|22200009
ensure
sufficient calcium|51117008|5540006
in the blood.|87612001|119273009

The role
of calcitonin,|63730009|127383000
a hormone|87568004
generated
by the thyroid|69748006|61020000
that
increases|260366006
bone deposition,|272673000|46595003|3138006|46595003|90780006|46595003|128530007|46595003
is
less
clear|263707001
and
probably
not
as significant|386134007
as that
of PTH.[9]

The activation
of osteoclasts|27770000
is
regulated
by various molecular signals,|256220008|290005005
of which
the receptor activator|116647005
for nuclear factor ?B ligand|84640000|259787006
(RANKL
is
one|421379005
of best
studied.|110465008|224699009

This molecule|290005005
is
produced
by osteoblasts|48156001
and
other cells|74964007|4421005
(e.g.|258795003

lymphocytes,|56972008|446325007
and
stimulates
RANK|263486008
(receptor activator|116647005
of nuclear factor ?B|84640000|259787006
).

Osteoprotegerin (OPG)
binds|257768005
RANKL
before
it
has
an opportunity to
bind|257768005
to
RANK|263486008
,
and
hence
suppresses|245780008
its ability to|371150009
increase|260366006
bone resorption.|22200009

RANKL,
RANK|263486008
and
OPG
are
closely
related|272151006|262094002
to tumor necrosis factor|8612007
and
its receptors.|116647005

The role
of the Wnt signaling pathway|38952000
is
recognized,
but
less well understood.|276139006|20572008|66216009|263796003|20572008|66216009

Local production|255470001
of eicosanoids|418534004
and
interleukins|38476002
is
thought to|88952004
participate
in the regulation
of bone turnover,|272673000|261032004|3138006|261032004|90780006|261032004|128530007|261032004
and
excess|260378005
or
reduced production|260400001
of these mediators
may
underlie|255546002
the development|278923009
of osteoporosis.[9]|64859006

Trabecular bone|20870005
(
or
cancellous bone|20870005
)
is
the sponge-like bone|20870005
in the ends|261782000
of long bones|113193004
and
vertebrae.|420345000

Cortical bone|87791003|32217005
is
the hard outer shell|72505002|261074009|44537007
of bones|272673000|128530007
and
the middle|255562008|399488007
of long bones.|113193004

Because
osteoblasts|48156001
and
osteoclasts|27770000
inhabit
the surface|410678000
of bones,|272673000|128530007
trabecular bone|20870005
is
more active,|242762006|55561003
so
is
more
subject to bone turnover|272673000|261032004|3138006|261032004|90780006|261032004|128530007|261032004
and
remodeling.

Not only
is
bone density|272673000|125146005|3138006|125146005|90780006|125146005|128530007|125146005
decreased|1250004|260400001|260371004
,
but
the microarchitecture
of bone|272673000|3138006|90780006|128530007
is
also
disrupted.

The weaker spicules|13791008|260407003
of trabecular bone break|20870005
("
microcracks
"
)
,
and
are
replaced|282089006|370124000
by weaker bone.|13791008|272673000|13791008|3138006|13791008|90780006|13791008|128530007|260407003|272673000|260407003|3138006|260407003|90780006|260407003|128530007

Common osteoporotic fracture sites,|72906007|46675001|10546003
the wrist,|8205005|361289009|74670003
the hip|29836001|85710004
and
the spine,|421060004|44300000|243930007
have
a relatively high trabecular bone|75540009|20870005|371879000|20870005
to cortical bone ratio.|87791003|118586006|32217005|118586006

These areas|42798000
rely
on trabecular bone|20870005
for strength,|260404005
so
the intense remodeling|103370009
causes|134198009
these areas to|42798000
degenerate|33359002
most
when
the remodeling
is
imbalanced._[citation
needed|410525008|103325001
_]
Around the ages|424144002
of 30?35,
cancellous
or
trabecular bone loss|231734003|312894000|82736000|312894000|20870005|312894000
begins.|255395001

Women|224526002
may
lose
as much|242762006|4757001
as 50%,
while
men|339947000
lose
about 30%.[1]

The diagnosis|439401001
of osteoporosis|64859006
can
be
made
using|260676000
conventional radiography|255333006|255333006|363680008
and
by measuring|258104002|263571004
the bone mineral density (BMD).|272673000|87918000|125146005|3138006|87918000|125146005|90780006|87918000|125146005|128530007|87918000|125146005

The most popular method|4757001|260686004|4757001|272394005
of measuring BMD|258104002|263571004
is
dual-energy x-ray absorptiometry.|248272003|248272003|52250000|248272003|168537006|248272003|363680008

In addition|260364009
to the detection
of abnormal BMD,|263654008
the diagnosis|439401001
of osteoporosis|64859006
requires
investigations|386053000
into potentially modifiable underlying causes|134198009
;
this
may
be
done
with blood tests.|252275004

Depending
on the likelihood|2931005
of an underlying problem,|55607006
investigations|386053000
for cancer|363346000|372087000
with metastasis|128462008
to the bone,|272673000|3138006|90780006|128530007
multiple myeloma,|55921005
Cushing's disease|190502001
and
other above-mentioned causes|74964007|134198009
may
be
performed.|398166005

Conventional radiography|255333006|255333006|363680008
is
useful,
both
by itself
and
in conjunction with CT
or
MRI,|113091000
for detecting complications|260373001|116223007
of osteopenia|312894000
(reduced bone mass|260400001|272673000|300848003|260400001|272673000|118538004|260400001|3138006|300848003|260400001|3138006|118538004|260400001|90780006|300848003|260400001|90780006|118538004|260400001|128530007|300848003|260400001|128530007|118538004
; preosteoporosis
)
,
such as fractures|125605004
;
for differential diagnosis|47965005
of osteopenia|312894000
;
or
for follow-up examinations
in specific clinical settings,|69658003|58147004
such as soft tissue calcifications,|181607009|181607009
secondary hyperparathyroidism,|91478007
or
osteomalacia|4598005
in renal osteodystrophy.|16726004

However,
radiography|363680008
is
relatively insensitive
to detection
of early disease|264499004|64572001
and
requires
a substantial amount|107651007
of bone loss|312894000
(about 30%
)
to
be
apparent
on X-ray images.|52250000|168537006|363680008

The main radiographic features|63161005|258106000
of generalized osteoporosis|60132005|64859006
are
cortical thinning|68594002|29143009|40146001|29143009|50403003|29143009
and
increased radiolucency.|35105006|263850002|260366006|263850002

Frequent complications|70232002|116223007
of osteoporosis|64859006
are
vertebral fractures|50448004
for which spinal radiography|363680008
can
help
considerably
in diagnosis|439401001
and
follow-up.|308273005

Vertebral height measurements|420345000|272391002
can
objectively
be
made
using|260676000
plain-film X-rays|168537006
by
using|260676000
several methods|261028005|260686004|261028005|272394005
such as height loss|71781005
together with area reduction,|397441001
particularly
when
looking|386548000
at vertical deformity|33096000|276654001|33096000|127560004|33096000|417893002
in T4-L4,
or
by determining
a spinal fracture index|50448004|419205000
that
takes|419652001
into
account
the number|410680006|410681005
of vertebrae|420345000
involved.|248448006

Involvement|248448006
of multiple vertebral bodies|260396001|3572006
leads|88488004|236874000
to kyphosis|414564002|71311003
of the thoracic spine,|122495006|243931006
obvious
to the clinician
as "dowager's hump".|414048000

A number|410680006|410681005
of clinical decision rules|58147004|10828004
have
been
created
to
predict
the risk|30207005
of osteoporotic fractures.|46675001

The QFracture score|278061009
was
developed
in 2009
and
is
based|418836005
on age,|424144002
BMI,
smoking|365981007
status,|263490005
alcohol use,|160573003
rheumatoid arthritis,|69896004
cardiovascular disease,|49601007
type 2 diabetes,|44054006
asthma,|195967001
use|277889008|419385000
of tricyclic antidepressants|373253007
or
corticosteroids,|79440004
liver disease,|235856003
and
a history|392521001
of falls|1912002
in men.|339947000

In women,|224526002
hormone replacement therapy,|266717002
parental history|40683002|40683002|392521001
of osteoporosis,|64859006
gastrointestinal malabsorption,|32230006
and
menopausal symptoms|21801002
are
also
taken|419652001
into account.

A website
is
available to|103328004
help
apply|410618006|417924000
this score.[47]|278061009

Dual-energy X-ray absorptiometry|248272003|248272003|52250000|248272003|168537006|248272003|363680008
(DXA
)
is
considered
the gold standard|2309006|371256005
for the diagnosis|439401001
of osteoporosis.|64859006

Osteoporosis|64859006
is
diagnosed|439401001
when
the bone mineral density|272673000|87918000|125146005|3138006|87918000|125146005|90780006|87918000|125146005|128530007|87918000|125146005
is
less
than
or
equal|9726003
to 2.5 standard deviations|264655001|386136009
below that
of a young adult reference population.|84422007|133936004|385436007|84422007|133936004|389109008

This
is
translated
as a T-score.|28913000|278061009

The World Health Organization|263775005|21139007
has
established|263748003|385645004
the following diagnostic guidelines|255260001|439401001|255260001|261004008
:
[2][14]|260306008

When
there
has
also
been
an osteoporotic fracture|46675001
(also
termed
"low trauma-fracture"|46675001
or
"fragility fracture"|59955000|125605004
)
,
defined
as one|421379005
that
occurs|272120004
as a result|394617004
of a fall|1912002
from a standing height,|248333004
the term "severe|24484000
or
established" osteoporosis|263748003|64859006|385645004|64859006
is
used.[2]|394850002

The International Society
for Clinical Densitometry|58147004
takes|419652001
the position|246449006
that
a diagnosis|439401001
of osteoporosis|64859006
in men|339947000
under 50 years|258707000
of age|424144002
should
not
be
made
on the basis|418836005
of densitometric criteria
alone.|105529008

It also
states|398070004
,
for premenopausal women,|224526002
Z-scores|373065002
(comparison
with age group|424144002|261586004|424144002|160481000|424144002|389109008
rather than
peak bone mass|255587001|272673000|300848003|255587001|272673000|118538004|255587001|3138006|300848003|255587001|3138006|118538004|255587001|90780006|300848003|255587001|90780006|118538004|255587001|128530007|300848003|255587001|128530007|118538004
)
rather than
T-scores|278061009
should
be
used|394850002
,
and
the diagnosis|439401001
of osteoporosis|64859006
in such women also|224526002
should
not
be
made
on the basis|418836005
of densitometric criteria alone.[48]|105529008

Chemical biomarkers|441900009
are
a useful tool|86967005
in detecting bone degradation.|260373001|272673000|40091007|260373001|3138006|40091007|260373001|90780006|40091007|260373001|128530007|40091007

The enzyme cathepsin K|90668006|130668008
breaks
down type-I collagen protein,|58520002|88878007
an important constituent|312297002
in bones.|272673000|128530007

Prepared antibodies|406205008|68498002
can
recognize
the resulting fragment,|42752001|29140007
called
a neoepitope,
as
a way to
diagnose|439401001
osteoporosis.|64859006

Increased urinary excretion|35105006|63911002|260366006|63911002
of C-telopeptides,
a type-I collagen breakdown product,|258191002|61472002|40091007|258191002|61472002|125366008
also
serves
as a biomarker
for osteoporosis.[50]|64859006

Quantitative computed tomography|30766002|77477000
differs
from DXA
in
that
it
gives|419582001
separate estimates|263869007|414135002
of BMD
for trabecular|231734003|82736000|20870005
and
cortical bone|87791003|32217005
and
reports|229059009|223458004
precise volumetric mineral density|262266004|87918000|125146005
in mg/cm3|427264006|258773002
rather than
BMD's relative Z score.|125677006|373065002|29920004|373065002

Among QCT's advantages|22059005
:
it
can
be
performed|398166005
at axial|24422004
and
peripheral sites,|14414005|10546003
can
be
calculated|258090004
from existing CT scans|77477000
without a separate radiation dose,|263869007|30821001|277406006|263869007|30821001|408102007|263869007|82107009|277406006|263869007|82107009|408102007|263869007|108290001|277406006|263869007|108290001|408102007
is
sensitive to change over time,|83185005|243326001|21481007|410669006|83185005|263703002|21481007|410669006
can
analyze
a region|410673009
of any size|277049003
or
shape,|107644003|246176004|300842002
excludes|77765009
irrelevant tissue|85756007
such as fat,|271590003
muscle,|91727004
and
air,|417696007
and
does
not
require
knowledge|225795001
of the patient's subpopulation|116154003|389109008
in order to
create
a clinical score|58147004|278061009
(e.g.|258795003

the Z-score|373065002
of all females|248152002
of a certain age|17162000|424144002
).

Among QCT's disadvantages|22059005
:
it
requires
a high radiation dose|261829003|30821001|261829003|82107009|261829003|108290001
compared
to DXA,
CT scanners
are
large|255509001
and
expensive,
and
because
its practice
has
been
less
standardized
than BMD,
its results|394617004
are
more operator-dependent.|242762006|371154000

Peripheral QCT|14414005|22059005
has
been
introduced|127487003
to
improve|385425000|3442003|385633008
upon the limitations|246175000
of DXA
and
QCT.[45]|22059005

Quantitative ultrasound|30766002|359659005
has
many advantages
in assessing osteoporosis.|64859006

The modality
is
small,|255507004
no ionizing radiation|125576007
is
involved,|248448006
measurements|272391002
can
be
made
quickly
and
easily,|36203004
and
the cost
of the device|303607000|49062001
is
low|62482003|371880002
compared
with DXA
and
QCT devices.|22059005|303607000|22059005|49062001

The calcaneus|80144004
is
the most common skeletal site|4757001|72906007|113192009|10546003
for quantitative ultrasound assessment|30766002|359659005|386053000
because
it
has
a high percentage|75540009|118582008|371879000|118582008
of trabecular bone|20870005
that
is
replaced more often|282089006|70232002|370124000|70232002
than cortical bone,|87791003|32217005
providing
early evidence|264499004|18669006
of metabolic change.|243326001|263703002

Also,
the calcaneus|80144004
is
fairly flat|6041008|257564005
and
parallel,
reducing|260400001
repositioning errors.|308739004

The method|260686004|272394005
can
be
applied|410618006
to children,|410601007|160499008
neonates,|133933007
and
preterm infants,|395507008|44247006
just
as well as
to adults.|133936004

Once microimaging tools to|86967005
examine|64049009
specific aspects|69658003
of bone quality|272673000|263496004|3138006|263496004|90780006|263496004|128530007|263496004
are
developed
,
it
is
expected
that quantitative ultrasound|30766002|359659005
will
be
increasingly
used|394850002
in clinical practice.[45]|58147004

The [U.S.|223688001

Preventive Services Task Force]|278032008|278032008|285653008
(/wiki/U.S._Preventive_Services_Task_Force|223688001|278032008|223688001|278032008|285653008
)
(USPSTF
)
recommended
in 2011
that
all women 65 years|224526002|264695004|258707000
of age|424144002
or
older|70753007
should
be
screened|20135006|360156006
with bone densitometry.|272673000|3138006|90780006|128530007

They
recommend
screening women|20135006|224526002
of any age|424144002
with increased risk factors|35105006|80943009|260366006|80943009
that
puts
them at risk equivalent|410519009|9726003|410519009|258726008
to a 65 year old|264695004|258707000|70753007|264695004|259039008|70753007
without additional risk factors.|260364009|80943009

The most significant risk factors|371925005|80943009
is
lower body weight|128263001|27113001|128263001|272102008|128263001|39857003|261122009|27113001|261122009|39857003
(weight|27113001|272102008|39857003
< 70 kg|223574006|258683005
)
,
with less evidence|276139006|18669006|263796003|18669006
for history|392521001
of smoking|365981007
or
family history.|57177007

There
was
insufficient evidence to|71978007|18669006|423437008|18669006
make
recommendations
about the optimal intervals|385673002
for repeated screening|27582007|20135006
and
the appropriate age to|424144002
stop|422117008
screening.|20135006

Clinical prediction rules|58147004|10828004
are
available to|103328004
guide|106384005|303479009
selection|50606000
of women|224526002
ages|424144002|105436006|248280005
60?64
for screening.|20135006

The Osteoporosis Risk Assessment Instrument|64859006|225338004|57134006
may
be
the most sensitive.[52]|4757001|83185005

The USPSTF
concludes
the harm
versus
benefit
of screening|20135006
for osteoporosis|64859006
in men|339947000
of any age|424144002
is
unknown.|261665006

Others|74964007
have
,
however,
claimed screening|20135006
may
be
cost effective|255403003|254648000
in those 80
to 85 years|258707000
of age.[53]|424144002

Methods to|260686004|272394005
prevent
osteoporosis|64859006
include|55919000
changes|243326001|263703002
of lifestyle.|60134006

However,
medications|410942007
can
be
used|394850002
for prevention,|169443000
as well.|20572008

As a different concept,|263735002
osteoporosis ortheses|64859006
help
to
prevent
spine fractures|50448004
and
support|9096001|243114000
the building
up
of muscles._[citation|91727004
needed|410525008|103325001
_]
Fall|1912002
prevention|169443000
can
help
prevent
osteoporosis complications.|64859006|116223007

There
is
some evidence|18669006
for hip protectors specifically|29836001|85710004
among those
who
are
in care homes.[54]|261770009

Lifestyle prevention|60134006|169443000
of osteoporosis|64859006
is
in many aspects inversions|60844005|45027002
from potentially modifiable risk factors.|80943009

As tobacco smoking|365981007
and
unsafe alcohol intake|160573003
have
been
linked
with osteoporosis,|64859006
smoking|365981007
cessation
and
moderation
of alcohol intake|160573003
are
commonly
recommended
in the prevention|169443000
of osteoporosis.|64859006

Many other risk factors,|74964007|80943009
some modifiable
and
others|74964007
not modifiable,
such as genetic,|3950001|255395001
may
be
involved|248448006
in osteoporosis.[55]|64859006|264691008

Achieving
a higher peak bone mass|75540009|255587001|272673000|300848003|75540009|255587001|272673000|118538004|75540009|255587001|3138006|300848003|75540009|255587001|3138006|118538004|75540009|255587001|90780006|300848003|75540009|255587001|90780006|118538004|75540009|255587001|128530007|300848003|75540009|255587001|128530007|118538004|371879000|255587001|272673000|300848003|371879000|255587001|272673000|118538004|371879000|255587001|3138006|300848003|371879000|255587001|3138006|118538004|371879000|255587001|90780006|300848003|371879000|255587001|90780006|118538004|371879000|255587001|128530007|300848003|371879000|255587001|128530007|118538004
through exercise|61686008
and
proper nutrition|87276001|384759009
during adolescence|22396007
is
important
for the prevention|169443000
of osteoporosis.|64859006

Exercise|61686008
and
nutrition|87276001|384759009
throughout the rest|258157001
of the life|224130005
delays
bone degeneration.|272673000|33359002|3138006|33359002|90780006|33359002|128530007|33359002

Jogging,|1968006
walking|129006008
,
or
stair-climbing|258145005
at 70?90%|264705001|264703008
of maximum effort three times|398303009|19487008|421291004|410669006|398303009|19487008|421291004|417929005
per week,|258705008|259038000
along
with 1,500 mg|260305007|427264006
of calcium|5540006
per day,|258703001|259032004
increased bone density|125149003|272673000|125149003|3138006|125149003|90780006|125149003|128530007
of the lumbar|182343007
(lower|261122009
)
spine|421060004|44300000|243930007
by 5%|264706000|264605009
over 9 months.|258706009

Individuals already|125676002|385435006
diagnosed|439401001
with osteopenia|312894000
or
osteoporosis|64859006
should
discuss
their exercise|61686008
programs
with their physicians to|309343006
avoid
fractures.|125605004

Weight-bearing endurance exercise|249981005|88965008
plus
or
minus
exercises|61686008|229065009
to
strengthen
muscles|91727004
improve|385425000|3442003|385633008
bone strength|272673000|260404005|3138006|260404005|90780006|260404005|128530007|260404005
in those with osteoporosis.[57]|20401003|64859006|421463005|64859006

Whether
or
not calcium|5540006
(
with
or
without vitamin D|71516007|30178006
)
is
effective|255403003|254648000
in preventing osteoporosis|64859006|116699007|64859006
is
controversial.

A 2007 review
supported|9096001|243114000
its use|277889008|419385000
for prevention|169443000
in people|125676002
over the age|424144002
of 50 years.|258707000

A review
and
draft recommendation
by the United States Preventive Services Task Force|223688001|278032008|223688001|278032008|285653008
in 2012 found insufficient evidence to|404684003|71978007|18669006|404684003|423437008|18669006|71978007|18669006|423437008|18669006
determine
risk verses|30207005
harm
from supplementation
in women|224526002
before menopause|161712005
or
in men,|339947000
so
does
not
recommend
it
for this group.[59]|261586004|160481000|389109008

People|125676002
at risk|410519009
for osteoporosis|64859006
(e.g.|258795003

steroid use|116566001|277889008|116566001|419385000
)
are
generally
treated|28995006
with vitamin D|71516007|30178006
and
calcium supplements|5540006|373453009
and
often|70232002
with bisphosphonates.|372907000

Vitamin D supplementation|226314006
alone|105529008
does
not
prevent
fractures,|125605004
and
needs|410525008|103325001
to
be
combined|89780004
with calcium.|5540006

People|125676002
who
are
taking proton pump inhibitors|419652001|372525000
or
H2 antagonists|58516001
do
not absorb calcium carbonate well|387307005|20572008
;
calcium citrate|52209008
is
the supplement|373453009
of choice
in this population.|385436007|389109008

In renal disease,|90708001
more active forms|242762006|55561003|246176004
of vitamin D,|71516007|30178006
such as cholecalciferol|108943009|105029001
or
(1,
25-dihydroxycholecalciferol
or
calcitriol,|68206008
which
is
the main biologically active form|63161005|12893009|55561003|246176004
of vitamin D|71516007|30178006
)
is
used,|394850002
as
the kidney|64033007|17373004|181414000
cannot
adequately
generate
calcitriol|68206008
from calcidiol|88519001
(25-hydroxycholecalciferol|88519001
)
which
is
the storage form|48122007|246176004|440276004|246176004
of vitamin D.|71516007|30178006

In vitamin D assays,|71516007|58779000|71516007|272392009|30178006|58779000|30178006|272392009
vitamin D2|71516007
(ergocalitrol
)
is
not accurately
measured|258104002
,
therefore vitamin D3|108943009|105029001
(cholecalciferol|108943009|105029001
)
is
recommended
for supplementation.[62]

Just
as for treatment,|276239002|416118004
bisphosphonate|372907000
can
be
used|394850002
in cases|398241000|413769002
of very high risk.|260360000|30207005|260358002|15508007

Other medicines|74964007|410942007
prescribed
for prevention|169443000
of osteoporosis|64859006
include|55919000
raloxifene,|419530003
a selective estrogen receptor modulator.|415515000

Estrogen replacement therapy|61946003|182819002
remains
a good treatment|20572008|276239002|20572008|416118004
for prevention|169443000
of osteoporosis,|64859006
but
is
not
recommended
yet
unless
other indications|74964007|410666004
for its use|277889008|419385000
are
present,|52101004|246105001
as well.|20572008

There
is
uncertainty|64957009
and
controversy about
whether estrogen|61946003
should
be
recommended
in women|224526002
in the first decade|255216001|232714002
after the menopause.|161712005

In hypogonadal men,|339947000
testosterone|43688007|85470006
has
been
shown
to
give|419582001
improvement
in bone quantity|272673000|107651007|3138006|107651007|90780006|107651007|128530007|107651007
and
quality,|263496004
but
,
as of 2008,
no studies|110465008|224699009
of the effects|253861007
on fractures|125605004
or
in men|339947000
with a normal testosterone level|17621005|104957004|258744000|104957004
have
been
reported.[36]|229059009|223458004

Lifestyle changes|60134006|243326001|60134006|263703002
are
an important aspect
of treatment,|276239002|416118004
and
several medications|261028005|410942007
are
used|394850002
to
treat|395077000
osteoporosis,|64859006
depending
on gender.|263495000

Aerobics,|229072005
weight bearing,|249981005
and
resistance exercises|30714006|61686008|30714006|229065009
all
maintain|385630006
or
increase BMD|260366006
in postmenopausal women.|76498008|224526002

A major problem|255603008|55607006
is
gaining|35105006|255396000|260366006|260369004|398092000
long-term adherence
to therapy|276239002
from people|125676002
with osteoporosis|64859006
with half
not
taking|419652001
their medications|410942007
and
most
discontinuing|410546004|421286000
within one year.[64]|421379005|258707000|421379005|259039008

Most bisphosphonates|372907000
are
effective|255403003|254648000
in preventing fractures|125605004|116699007|125605004
of the vertebrae,|420345000
nonvertebral bones|272673000|128530007
and
hips[65]|29836001|264695004
when
taken|419652001
for three|421291004
to four years.|421534005|258707000

They
have
not
been
compared
directly
to each other,
though
,
so
it
is
not
known|36692007
if one|421379005
is
better|3442003
than the others.|74964007

Fracture risk reduction|122859005|30207005|125605004|405056001
is
between 25
and
70%
depending
on the bone|272673000|3138006|90780006|128530007
involved.|248448006

There
are
concerns
of atypical femoral fractures|112231000|71620000
and
osteonecrosis|240196003|398199007
of the jaw|661005|181811001
with long term use,|277889008|419385000
but
these risk|30207005
are
low.|62482003|371880002

With evidence|18669006
of little benefit
when
used|394850002
for more
than three to five years|421291004|421820001|258707000
and
in light|56242006|371268001
of the potential adverse events,|30207005|272379006
it
may
be
appropriate to
stop|422117008
treatment|276239002|416118004
after this time|410669006
in some.[66]

Teriparatide|425438001
(
a recombinant parathyroid hormone|428295002
)
has
been
shown
to
be
effective in treatment|255403003|276239002|255403003|416118004|254648000|276239002|254648000|416118004
of women|224526002
with postmenopausal osteoporosis.|102447009

Some evidence also|18669006
indicates|410535002
strontium ranelate|441487000
is
effective|255403003|254648000
in decreasing|260371004
the risk|30207005
of vertebral|420345000
and
nonvertebral fractures|125605004
in postmenopausal, osteoporotic women.|76498008|224526002

Hormone replacement therapy,|266717002
while
effective|255403003|254648000
for osteoporosis,|64859006
is
only
recommended
in women|224526002
who also
have
menopausal symptoms.|21801002

Raloxifene,|419530003
while
effective|255403003|254648000
in decreasing vertebral fractures,|260371004|50448004
does
not
affect|4065008
the risk|30207005
of nonvertebral fracture.|125605004

And
while
it
reduces|260400001
the risk|30207005
of breast cancer,|254837009|254838004
it
increases|260366006
the risk|30207005
of blood clots|75753009
and
strokes.|230690007

Denosumab|446321003
is
also effective|255403003|254648000
for preventing osteoporotic fractures.|46675001|116699007|46675001

In hypogonadal men,|339947000
testosterone|43688007|85470006
has
been
shown
to
improve|385425000|3442003|385633008
bone quantity|272673000|107651007|3138006|107651007|90780006|107651007|128530007|107651007
and
quality,|263496004
but
no studies|110465008|224699009
evaluated
its effect|253861007
on fracture risk|125605004|30207005
or
in men|339947000
with a normal testosterone levels.[36]|17621005|104957004|258744000|104957004

Calcium|5540006
and
vitamin D|71516007|30178006
decrease|260400001|260370003
the risk|30207005
of nonvertebral fractures|125605004
in those with postmenopausal osteoporosis|20401003|102447009|421463005|102447009
by about 18%.

High intake|75540009|371879000
of vitamin D|71516007|30178006
reduces|260400001
fractures|125605004
in the elderly.|105436006

Vitamin K|65183007
prevents|116699007
bone loss|312894000
and/or
fractures|125605004
in those with postmenopausal osteoporosis.[70]|20401003|102447009|421463005|102447009

Although
osteoporosis patients|64859006|116154003
have
an increased mortality rate|35105006|409651001|260366006|409651001
due to the complications|116223007
of fracture,|125605004
it
is
rarely lethal.|103356009

Hip fractures
can
lead|88488004
to decreased mobility|8510008
and
additional risks|260364009|30207005
of numerous complications|260396001|116223007
(
such as deep venous thrombosis|128053003
and/or
pulmonary embolism,|59282003
and
pneumonia.|205237003

The six-month mortality rate|422218008|258706009|409651001|422218008|259036001|409651001
following|255260001
hip fracture
is
around 13.5%,
and
a substantial proportion|8212001
(almost 13%
)
of people|125676002
who
have
suffered
a hip fracture need total assistance to|410525008|258755000|116697009|410525008|255619001|116697009|103325001|258755000|116697009|103325001|255619001|116697009
mobilize|183376001|302044006
after a hip fracture.[72]

Vertebral fractures,|50448004
while
having
a smaller impact|263796003|134293005|255507004|134293005
on mortality,|409651001
can
lead|88488004
to severe chronic pain|76948002|90734009|24484000|82423001
of neurogenic origin,|255395001
which
can
be
hard to|72505002
control|31509003
,
as well as
deformity.|276654001|127560004|417893002

Though
rare, multiple vertebral fractures|84638005|134291007|420345000|103356009|134291007|420345000
can
lead|88488004
to such severe hunch back|24484000|414564002|24484000|71311003
(kyphosis,|414564002|71311003
the resulting pressure|42752001|279046003|42752001|13543005|42752001|257893003
on internal organs|260521003|410653004
can
impair|260379002|40226000
one's ability|421379005|371150009
to breathe.|14910006|258162000

Apart from risk|30207005
of death|419620001|268923008
and
other complications,|116223007
osteoporotic fractures|46675001
are
associated|47429007
with a reduced health-related quality|260400001|263775005|272151006|263496004|260400001|263775005|262094002|263496004
of life.[73]|224130005

Osteoporosis|64859006
affects|4065008
55%|264691008
of Americans
aged|424144002|105436006
50
and
above.|261183002

Of these,
approximately 80%|26175008
are
women.|224526002

One|421379005
in three women|421291004|224526002
and
one|421379005
in 12 men|339947000
over the age|424144002
of 50 worldwide
are
estimated|414135002
to
have
osteoporosis._[citation|64859006
needed|410525008|103325001
_]
It
is
responsible|394851003
for millions
of fractures annually,|125605004|53281000
mostly
involving|248448006
the lumbar vertebrae,|122496007
hip,|29836001|85710004
and
wrist.|8205005|361289009|74670003

Fragility|59955000
fractures|125605004
of ribs|113197003
are
also common|72906007
in men.|339947000

Hip fractures
are
responsible|394851003
for the most serious consequences|4757001|42745003|103332005
of osteoporosis.|64859006

In the United States,|223688001
more
than 250,000 hip|29836001|85710004
fractures|125605004
annually|53281000
are
attributable
to osteoporosis.|64859006

A 50-year-old white woman|258707000|70753007|413773004|224526002|258707000|70753007|185984009|224526002|258707000|70753007|371251000|224526002|259039008|70753007|413773004|224526002|259039008|70753007|185984009|224526002|259039008|70753007|371251000|224526002
is
estimated to|414135002
have
a 17.5% lifetime risk|30207005
of fracture|125605004
of the proximal femur.|244696009

The incidence
of hip fractures
increases|260366006
each decade
from the sixth|53046009
through the ninth|58584009
for
both
women|224526002
and
men|339947000
for all populations.|385436007

The highest incidence|75540009|371879000
is
found|404684003
among men|339947000
and
women|224526002
ages|424144002|105436006|248280005
80
or
older.[76]|70753007

Between 35
and
50%
of all women|224526002
over 50
had
at least one vertebral fracture.|276139006|421379005|50448004|263796003|421379005|50448004

In the United States,|223688001
700,000 vertebral fractures|50448004
occur|272120004
annually,|53281000
but
only
about a third|70905002
are
recognized.

In a series|13039001
of 9704 women|224526002
aged|424144002|105436006
68.8|264697007
on average
studied|110465008|224699009
for 15 years,|258707000
324
had
already
suffered
a vertebral fracture|50448004
at entry
into the study|110465008|224699009
and
18.2%
developed
a vertebral fracture,|50448004
but
that risk rose|30207005
to 41.4%
in women|224526002
who
had
a previous vertebral fracture.[77]|9130008|50448004

In the United States,|223688001
250,000 wrist|8205005|361289009|74670003
fractures|125605004
annually|53281000
are
attributable
to osteoporosis.|64859006

Wrist fractures|263208005
are
the third most common type|70905002|72906007|261664005
of osteoporotic fractures.|46675001

The lifetime risk|30207005
of sustaining|263892007
a Colles' fracture|123971006
is
about 16%
for white women.|413773004|224526002|185984009|224526002|371251000|224526002

By the time women|410669006|224526002
reach|282679008
age 70,|424144002
about 20%
have
had
at least one wrist fracture.[76]|276139006|421379005|263208005|263796003|421379005|263208005

Fragility|59955000
fractures|125605004
of the ribs|113197003
are
common|72906007
in men|339947000
as young|84422007
as age 35.|424144002

These
are
often|70232002
overlooked
as signs|72670004
of osteoporosis,|64859006
as
these men|339947000
are
often physically active|70232002|228447005
and
suffer
the fracture|125605004
in the course|288524001
of physical activity.|48761009

An example
would
be
as a result|394617004
of falling|1912002
while
water skiing|34310006
or
jet skiing.|102389002

However,
a quick test|255358001|269814003|255358001|255358001|272393004
of the individual's testosterone level|125676002|104957004|385435006|104957004
following|255260001
the diagnosis|439401001
of the fracture|125605004
will
readily
reveal|263857004
whether
that individual|125676002|385435006
might
be
at risk.|410519009

The link
between age-related reductions|424144002|272151006|58294000|424144002|272151006|289928003|424144002|262094002|58294000|424144002|262094002|289928003
in bone density|272673000|125146005|3138006|125146005|90780006|125146005|128530007|125146005
and
fracture risk goes|125605004|30207005
back
at least
to Astley Cooper,|28433008
and
the term "osteoporosis"|64859006
and
recognition|312020002
of its pathological appearance|394595002|386548000|394595002|255412001|29458008|386548000|29458008|255412001
is
generally
attributed|246061005
to the French pathologist Jean Lobstein.|19434008|61207006|228210008

The American endocrinologist Fuller Albright|61894003
linked
osteoporosis|64859006
with the postmenopausal state.|76498008

Bisphosponates,
which
revolutionized
the treatment|276239002|416118004
of osteoporosis,|64859006
were
discovered
in the 1960s.[80]

M
:
BON/CAR|71783008

anat(c/f/k/f,
u,
t/p,
l/phys/devp/cell|258995007|4421005|258995007|362837007|420559008|4421005|420559008|362837007

noco/cong/tumr,
sysi/epon,
injr

proc,
drug|410942007
(M5

